Hence, in addition to the transmembrane VEGFR1, soluble isoforms of the receptor (sVEGFR1s) which arise from cleavage of full-lenght VEGFR1 or from alternative splicing of VEGFR1 pre-mRNA are produced by endothelial and also tumor cells. This evidence concerns the gene FLT1 and neoplasm.